IRF3 inhibits nuclear translocation of NF-κB to prevent viral inflammation.

Popli, Sonam; Chakravarty, Sukanya; Fan, Shumin; Glanz, Anna; Aras, Siddhesh; Nagy, Laura E; Sen, Ganes C; Chakravarti, Ritu et al. · Proc Natl Acad Sci U S A · 2022

basic_science · Level V

Where this comes from

Abstract

Interferon (IFN) regulatory factor 3 (IRF3) is a transcription factor activated by phosphorylation in the cytoplasm of a virus-infected cell; by translocating to the nucleus, it induces transcription of IFN-β and other antiviral genes. We have previously reported IRF3 can also be activated, as a proapoptotic factor, by its linear polyubiquitination mediated by the RIG-I pathway. Both transcriptional and apoptotic functions of IRF3 contribute to its antiviral effect. Here, we report a nontranscriptional function of IRF3, namely, the repression of IRF3-mediated NF-κB activity (RIKA), which attenuated viral activation of NF-κB and the resultant inflammatory gene induction. In <i>Irf3<sup>-/-</sup></i> mice, consequently, Sendai virus infection caused enhanced inflammation in the lungs. Mechanistically, RIKA was mediated by the direct binding of IRF3 to the p65 subunit of NF-κB in the cytoplasm, which prevented its nuclear import. A mutant IRF3 defective in both the transcriptional and the apoptotic activities was active in RIKA and inhibited virus replication. Our results demonstrated IRF3 deployed a three-pronged attack on virus replication and the accompanying inflammation.

Medical subject headings